Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Not applicableStudy completedNCT06648512
What this trial is testing

Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Relapse
Exscientia AI Limited 91
Large-scale testing (Phase 3)Study completedNCT00835770
What this trial is testing

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 1,736
Not applicableStudy completedNCT00266773
What this trial is testing

A Telephone Feedback System for Prevention of Chronic Pain Relapse

Who this might be right for
Chronic Pain and Relapse Prevention
University of Vermont 158
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Testing effectiveness (Phase 2)UnknownNCT03502629
What this trial is testing

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Who this might be right for
Peripheral T Cell Lymphoma
Genor Biopharma Co., Ltd. 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682675
What this trial is testing

Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck

Who this might be right for
Adenoid Cystic Carcinoma of the Salivary GlandRecurrenceMetastatic Disease
UNICANCER 51
Large-scale testing (Phase 3)Study completedNCT03009981
What this trial is testing

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance Foundation Trials, LLC. 504
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266
What this trial is testing

Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 23
Not applicableStudy completedNCT04655222
What this trial is testing

Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 470
Testing effectiveness (Phase 2)Looking for participantsNCT06235229
What this trial is testing

GC012F in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd. 110
Very early researchLooking for participantsNCT07048353
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Who this might be right for
LymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Large-scale testing (Phase 3)Study completedNCT01147939
What this trial is testing

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Clavis Pharma 381
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Study completedNCT02077166
What this trial is testing

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Pharmacyclics LLC. 138
Very early researchWithdrawnNCT07338357
What this trial is testing

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Who this might be right for
AML (Acute Myeloid Leukemia)CAR-T
First Affiliated Hospital of Guangxi Medical University
Early research (Phase 1)WithdrawnNCT06411301
What this trial is testing

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in RelapseMultiple Myeloma Progression
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Looking for participantsNCT06495723
What this trial is testing

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS 54
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Next Page